• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Insights from protein frustration analysis of BRD4-cereblon degrader ternary complexes show separation of strong from weak degraders.BRD4-脑啡肽降解剂三元复合物的蛋白质错配分析见解显示了强效降解剂与弱效降解剂的区分。
RSC Med Chem. 2025 Feb 10. doi: 10.1039/d4md00962b.
2
Structural Characterization of Degrader-Induced Ternary Complexes Using Hydrogen-Deuterium Exchange Mass Spectrometry and Computational Modeling: Implications for Structure-Based Design.使用氘氢交换质谱和计算建模对降解剂诱导的三元复合物进行结构表征:对基于结构设计的启示。
ACS Chem Biol. 2021 Nov 19;16(11):2228-2243. doi: 10.1021/acschembio.1c00376. Epub 2021 Sep 28.
3
Interplay of PROTAC Complex Dynamics for Undruggable Targets: Insights into Ternary Complex Behavior and Linker Design.用于不可成药靶点的PROTAC复合物动力学的相互作用:对三元复合物行为和连接子设计的见解
ACS Med Chem Lett. 2024 Jul 29;15(8):1306-1318. doi: 10.1021/acsmedchemlett.4c00189. eCollection 2024 Aug 8.
4
Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.基于 CRBN 招募型 PROTAC 预测靶蛋白泛素化的 CRL4A 连接酶复合物建模。
J Biol Chem. 2022 Apr;298(4):101653. doi: 10.1016/j.jbc.2022.101653. Epub 2022 Jan 29.
5
PROTAC-induced Protein Structural Dynamics in Targeted Protein Degradation.靶向蛋白质降解中PROTAC诱导的蛋白质结构动力学
bioRxiv. 2025 Jan 20:2024.05.05.592590. doi: 10.1101/2024.05.05.592590.
6
Affinity and cooperativity modulate ternary complex formation to drive targeted protein degradation.亲和力和协同性调节三元复合物形成以驱动靶向蛋白降解。
Nat Commun. 2023 Jul 13;14(1):4177. doi: 10.1038/s41467-023-39904-5.
7
PROTAC-induced protein structural dynamics in targeted protein degradation.PROTAC诱导的靶向蛋白质降解中的蛋白质结构动力学
Elife. 2025 Feb 27;13:RP101127. doi: 10.7554/eLife.101127.
8
Characterization of cereblon-dependent targeted protein degrader by visualizing the spatiotemporal ternary complex formation in cells.通过可视化细胞中三元复合物的形成来研究 cereblon 依赖性靶向蛋白降解剂。
Sci Rep. 2020 Feb 20;10(1):3088. doi: 10.1038/s41598-020-59966-5.
9
SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate.SPR 测量的 PROTAC 三元复合物离解动力学影响靶标降解速率。
ACS Chem Biol. 2019 Mar 15;14(3):361-368. doi: 10.1021/acschembio.9b00092. Epub 2019 Feb 22.
10
Cellular Resistance Mechanisms to Targeted Protein Degradation Converge Toward Impairment of the Engaged Ubiquitin Transfer Pathway.细胞对靶向蛋白降解的抵抗机制趋于损害结合的泛素转移途径。
ACS Chem Biol. 2019 Oct 18;14(10):2215-2223. doi: 10.1021/acschembio.9b00525. Epub 2019 Oct 8.

引用本文的文献

1
Protein Frustration Reveals Active Sites in Co-Evolved GPCR:G Protein Complexes and in Engineered Targeted Degrader Complexes.蛋白质构象受挫揭示了共同进化的G蛋白偶联受体(GPCR):G蛋白复合物以及工程化靶向降解复合物中的活性位点。
bioRxiv. 2025 Jun 28:2025.06.27.660602. doi: 10.1101/2025.06.27.660602.

本文引用的文献

1
PROTAC-induced protein structural dynamics in targeted protein degradation.PROTAC诱导的靶向蛋白质降解中的蛋白质结构动力学
Elife. 2025 Feb 27;13:RP101127. doi: 10.7554/eLife.101127.
2
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression.BRD4 特异性 PROTAC 通过下调 KLF5 表达部分抑制基底样乳腺癌。
Oncogene. 2024 Sep;43(39):2914-2926. doi: 10.1038/s41388-024-03121-1. Epub 2024 Aug 20.
3
PROTAC technology: From drug development to probe technology for target deconvolution.PROTAC 技术:从药物研发到靶标解析探针技术。
Eur J Med Chem. 2024 Oct 5;276:116725. doi: 10.1016/j.ejmech.2024.116725. Epub 2024 Jul 30.
4
Exosome-mediated PROTAC delivery for treatment of RNA viral infections and zoonosis.外泌体介导的 PROTAC 递送用于治疗 RNA 病毒感染和人畜共患病。
Drug Discov Today. 2024 Jul;29(7):104044. doi: 10.1016/j.drudis.2024.104044. Epub 2024 May 23.
5
Research progress of PROTACs for neurodegenerative diseases therapy.神经退行性疾病治疗的 PROTACs 研究进展。
Bioorg Chem. 2024 Jun;147:107386. doi: 10.1016/j.bioorg.2024.107386. Epub 2024 Apr 18.
6
Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development.革新药物靶向策略:在PROTAC开发中整合人工智能与基于结构的方法
Pharmaceuticals (Basel). 2023 Nov 24;16(12):1649. doi: 10.3390/ph16121649.
7
Local energetic frustration conservation in protein families and superfamilies.蛋白质家族和超家族中的局部能量挫折守恒。
Nat Commun. 2023 Dec 16;14(1):8379. doi: 10.1038/s41467-023-43801-2.
8
AmberTools. AmberTools。
J Chem Inf Model. 2023 Oct 23;63(20):6183-6191. doi: 10.1021/acs.jcim.3c01153. Epub 2023 Oct 8.
9
PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies.PROTACs:用于先进成药性策略的新兴靶向蛋白降解方法。
Molecules. 2023 May 10;28(10):4014. doi: 10.3390/molecules28104014.
10
On Ternary Complex Stability in Protein Degradation: In Silico Molecular Glue Binding Affinity Calculations.关于蛋白质降解中三元复合物稳定性的研究:计算机分子胶结合亲和力的计算。
J Chem Inf Model. 2023 Apr 24;63(8):2382-2392. doi: 10.1021/acs.jcim.2c01386. Epub 2023 Apr 10.

BRD4-脑啡肽降解剂三元复合物的蛋白质错配分析见解显示了强效降解剂与弱效降解剂的区分。

Insights from protein frustration analysis of BRD4-cereblon degrader ternary complexes show separation of strong from weak degraders.

作者信息

Yang Tianyi, Mukhaleva Elizaveta, Wei Wenyuan, Weiss Dahlia, Ma Ning, Shanmugasundaram Veerabahu, Vaidehi Nagarajan

机构信息

Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope 1500, E. Duarte Road Duarte CA 91010 USA

Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope USA.

出版信息

RSC Med Chem. 2025 Feb 10. doi: 10.1039/d4md00962b.

DOI:10.1039/d4md00962b
PMID:40012705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11851170/
Abstract

PROteolysis TArgeting Chimeras (PROTACs), also known as ligand-directed degraders (LDDs), are an innovative class of small molecules that leverage the ubiquitin-proteasome system to induce the degradation of target proteins. Structure based design methods are not readily applicable for designing LDDs due to the dynamic nature of the ternary complexes. This study investigates the dynamic properties of five LDD-mediated BRD4-cereblon complexes, focusing on the challenges of evaluating linker efficiency due to the difficulty in identifying suitable computational metrics that correlate well with the cooperativity or degradation propensity of LDDs. We uncovered that protein frustration, a concept originally developed to understand protein folding, calculated for the residues in the protein-protein interface of the LDD-mediated ternary complexes recapitulate the strength of degradation of the LDDs. Our findings indicated that hydrophobic residues in the interface are among the highly frustrated residues pairs, and they are crucial in distinguishing strong degraders from weak ones. By analyzing frustration patterns, we identified key residues and interactions critical to the effectiveness of the ternary complex. These insights provide practical guidelines for designing and prioritizing more efficient degraders, paving the way for the development of next-generation LDDs with improved therapeutic potential.

摘要

蛋白酶靶向嵌合体(PROTACs),也被称为配体导向降解剂(LDDs),是一类创新的小分子,它们利用泛素-蛋白酶体系统诱导靶蛋白降解。由于三元复合物的动态性质,基于结构的设计方法不易应用于设计LDDs。本研究调查了五种LDD介导的BRD4-脑啡肽复合物的动态特性,重点关注评估连接子效率的挑战,因为难以确定与LDDs的协同性或降解倾向良好相关的合适计算指标。我们发现,蛋白质受挫感,这一最初为理解蛋白质折叠而提出的概念,计算LDD介导的三元复合物蛋白质-蛋白质界面中的残基时,能够概括LDDs的降解强度。我们的研究结果表明,界面中的疏水残基属于高度受挫的残基对,它们对于区分强效降解剂和弱效降解剂至关重要。通过分析受挫模式,我们确定了对三元复合物有效性至关重要的关键残基和相互作用。这些见解为设计和优先选择更有效的降解剂提供了实用指南,为开发具有更高治疗潜力的下一代LDDs铺平了道路。